Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Astellas Pharma describes prostanoid EP4 antagonists

Oct. 14, 2015

New financing round at Pharmalink to fund development of phase III program for Nefecon

Oct. 6, 2015

Fexeric approved in Europe for hyperphosphatemia in patients with chronic kidney disease

Sep. 25, 2015

NecroX-7 reduces renal ischemia-reperfusion injury in vivo

Sep. 17, 2015

Topline phase II data on GKT-137831 support development in fibrotic diseases

Sep. 9, 2015

Cytori stem cell therapy ECCS-50 enters phase III trial in male urinary incontinence

Sep. 8, 2015

Sanofi terminates option to license Ardelyx's RDX-002 program

Sep. 4, 2015

CSIR scientists describe PDE5A inhibitors

Aug. 21, 2015

FDA approves Procysbi for children aged 2-6 years with nephropathic cystinosis

Aug. 18, 2015

First patients randomized in phase IIa trial of SER-150 in diabetic nephropathy

Aug. 17, 2015

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...